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ABSTRACT 
 Currently, there is a dearth of knowledge regarding pediatric Complex Regional 
pain syndrome (CRPS), whether it is in regards to its pathophysiological mechanisms, 
pediatric-specific diagnostic criteria, validated diagnostic tests, conclusive treatment 
regimens, or validation of invasive and noninvasive treatment protocols in the pediatric 
CRPS population. It is imperative to first explore and establish a pediatric CRPS 
diagnostic criteria in order to optimize diagnostic accuracy for clinical and research 
purposes.  
 This study first examined the efficacy of the Budapest criteria, a validated 
diagnostic instrument for adult CRPS, in the pediatric population. The test was 
administered to 221 pediatric patients at the Pediatric Pain Rehabilitation Center (PPRC), 
an intensive day treatment program at Boston Children’s Hospital for youth with chronic 
pain, and included both CRPS and non-CRPS chronic pain patients. Utilizing the 
Budapest criteria, secondary analyses were performed to determine whether the pediatric 
CRPS patients had an alleviation of their diagnosis from admission to discharge from the 
program.  
		 vi 
 The Budapest clinical decision rule (to satisfy at least 2 signs categories and 3 
symptoms categories) was utilized in examining the data. The sensitivity, specificity, 
positive likelihood ratio (PLR), and negative likelihood ratio (NLR) of the Budapest 
criteria in the pediatric sample were 0.56, 0.95, 10.39, and 0.47, respectively. The low 
sensitivity and high specificity was in contrast to the adult findings, and suggests that the 
Budapest criteria would be appropriate when the primary purpose is to identify stringent 
research samples as opposed to maximizing clinical diagnoses of CRPS. The likelihood 
ratios indicated that while satisfying the Budapest clinical decision rule may conclusively 
increase the probability of the pediatric patient actually having CRPS, a negative test 
does not significantly decrease the probability of the patient having CRPS. Therefore, 
modifications that appropriately increase the sensitivity while maintaining the high 
specificity of the Budapest Criteria are recommended. 
 Repeated measures ANOVA resulted in a significant decrease of the Budapest 
signs and symptoms score in the 94 pediatric CRPS patients in the sample, both in the 
Clinician + Budapest (satisfied the Budapest clinical decision rule) and Clinician 
Diagnosed (did not satisfy the Budapest clinical decision rule) CRPS cohorts (p < 0.001). 
This further authenticated the use of a multidisciplinary treatment approach in managing 
pediatric CRPS, as the program was successful in alleviating the patients’ signs and 
symptoms.  
 Further research must be conducted to explore the improvements that can be made 
to the Budapest Criteria for its use in pediatric CRPS so as to maximize its diagnostic 
accuracy. Overall, this study corroborated the use of interdisciplinary treatment regimens 
		 vii 
for pediatric CRPS, but further rigorous investigation is necessary to elucidate the 
mechanisms behind pediatric CRPS and the rehabilitation programs’ success in managing 
CRPS.   
		 viii 
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INTRODUCTION 
 	 Complex Regional Pain Syndrome (CRPS), also commonly referred to as Reflex 
Sympathetic Dystrophy and causalgia, is a debilitating chronic pain condition that often 
affects one of the extremities, the upper extremity in particular (Harden et al., 2007; 
Borchers & Gershwin, 2014; Wolter et al., 2016; Imani et al., 2016). Generally, CRPS 
manifests following trauma such as nerve injury, surgery, immobilization, or a 
musculoskeletal injury, in which the severity is disproportionate to the degree of pain; 
however, the condition may even occur spontaneously (Goebel, 2011). Designated as a 
rare disease, it has been reported that the estimated overall incidence of CRPS in the 
Netherlands was 26.2 cases/100,000 person years, whereas that in the United States was 
5.5 cases per 100,000 person years (Sebastin, 2011). Moreover, the incidence of CRPS is 
higher in patients between ages 40-49 and in women with a prevalence of 23% and 76%, 
respectively (Veldman et al., 1993).  
 There have been several studies investigating the influence of psychosocial 
factors and their degree of influence in precipitating CRPS. In fact, several studies have 
demonstrated that psychosocial factors are not predispositional to the onset of CRPS. De 
Mos et al. (2008) examined whether preexisting psychological factors such as depression, 
anxiety, and stress were associated with CRPS onset, but did not find any significant 
relationships. Furthermore, a prospective study was conducted to observe whether 
psychological factors predict the precipitation of CRPS following total knee arthroplasty, 
as this surgery is associated with development of CRPS (Harden et al., 2003). Results 
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showed that although CRPS patients reported more anxiety and depression after the 
surgery, anxiety and depression before the surgery did not predict the onset of CRPS, 
suggesting that the two factors are not predictive but rather an outcome of CRPS (Harden 
et al., 2003). An additional area of interest in CRPS patients is their quality of life; a 
study showed that discharged CRPS patients reported decreased social and emotional 
function, impaired physical function, and heightened physical pain compared to healthy 
controls (Savas et al., 2008). A small-sample study also observed that CRPS patients 
reported significant impairments in daily activities such as work, sleep, and social 
activities (Galer et al., 2000). These studies demonstrate that while the predicting role of 
psychosocial factors in the development of CRPS is not fully corroborated, the findings 
clearly show how psychological impairments such as depression and anxiety commonly 
follow the onset of CRPS (Lohnberg & Altmaier, 2013). Treatment of CRPS further 
poses a financial burden to the patients just like other chronic pain conditions, and since 
patients with continuing pain from CRPS are discouraged to work, the overall healthcare 
costs are higher and quality of life poorer (Goebel, 2011). This emphasizes the 
importance of addressing the psychosocial and socioeconomic factors along with the 
physical factors in understanding and treating CRPS patients. 
 Pediatric CRPS is a relatively recent diagnostic entity. Similar to the adult 
population, pediatric CRPS is more common in females, yet it is mainly confined to the 
lower extremities (Low et al., 2007). Recently, there has been considerable progress in 
research regarding the effectiveness of noninvasive, interdisciplinary treatment approach 
for pediatric CRPS, with a high success rate in improving the conditions (Lee et al., 2002; 
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Logan et al., 2012; Logan et al., 2015; Low et al., 2007; Katholi et al., 2014). Examples 
of such improvement in children with CRPS include occupational performance, 
emotional functioning, physical ability, and sleep habits (Logan et al., 2015; Logan et al., 
2012). Until recently, pain in children has been inadequately managed at institutions 
(Dowden et al., 2008). But novel advancements have been proposed and executed to 
establish pediatric pain treatment programs that incorporate the interdisciplinary 
approach (Kost-Byerly & Chalkiadis, 2012; Evans et al., 2012; Hechler et al., 2014). 
Currently, pediatric CRPS lacks standardized diagnostic tests, thus it is imperative to first 
validate a pediatric diagnostic test in order to accurately diagnose pediatric CRPS patients 
with high specificity and sensitivity. 
 
Pathophysiology of CRPS 
 In addition to the significant pain, the signs and symptoms of CRPS include but 
are not limited to: swelling, allodynia (experiencing pain from non-painful stimulus), 
hyperalgesia (disproportionately increased sensitivity to pain), dystonia, edema, 
decreased range of motion, abnormalities in skin color, temperature, and changes in hair 
and nail growth (Bean et al., 2014). Despite an increase in CRPS research during the past 
decade to elucidate its etiology, the exact pathophysiologic mechanisms behind this 
neuropathic pain disorder remains largely unknown. The widely accepted theory is that it 
is multifactorial in nature; the condition may be due to a dysfunctional interaction 
between the peripheral and central nervous system, inappropriate inflammation, 
maladaptive sympathetic and catecholaminergic function, psychosocio-physiologic 
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interactions, and genetic risk factors (Rockett, 2014; Sebastin, 2011; Blaes et al., 2004; 
Marinus et al., 2011; Bruehl, 2010).  The degree to which these mechanisms contribute to 
the symptoms of CRPS may vary on an individual basis and may even change within a 
patient over time (Bruehl, 2010). Determining the pathophysiological mechanism of 
CRPS and establishing explanatory models for the specific symptoms will not only aid in 
developing sensitive and specific diagnostic measures, but will also facilitate in the 
design of optimal treatment protocols and identify potential risk factors of CRPS after 
trauma, which may drastically decrease the incidence of CRPS following an initial 
noxious injury. 
 
Pediatric CRPS 
 CRPS has been underreported in pediatric populations until recently, with a study 
in 1999 being one of the first publications regarding treatment outcomes for pediatric 
CRPS (Sherry et al., 1999). The majority of the research regarding pediatric CRPS has 
been conducted in the past decade (Stanton-Hicks, 2010; Goldschneider, 2012; Kachko et 
al., 2008; Logan et al., 2013; Rodrigues et al., 2015). Consequently, there is sparse 
clinical data and information regarding pediatric CRPS, which subsequently reiterates the 
urgency in advancing research for progress towards optimal treatment and prevention 
(Goldschneider, 2012). In fact, the data regarding pediatric CRPS is mainly derived from 
adult studies and findings (Goldschneider, 2012). This may be troublesome, as there may 
be various factors that are unique to pediatrics due to their developmental changes and 
growth. There is also a lack of information concerning the efficacy of the treatment 
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methods available for pediatric CRPS patients (Rodrigues et al., 2015). It has been shown 
that psychological factors have played a larger role in precipitating the disorder in 
children, and how multidisciplinary treatment is particularly successful in the pediatric 
population (Wilder, 2006).  
 One study regarding pediatric CRPS suggest that it occurred predominantly in 
females (90%), with a mean age of 11.8 years at diagnosis and mainly occurred in the 
lower extremities (85%), following a minor traumatic event (80%) (Low et al., 2007). 
This has been consistent with other studies regarding pediatric CRPS (Stanton-Hicks, 
2010; Wilder, 2006). Furthermore, it was found that there were significant diagnostic 
delays with an average of 13.6 weeks that resulted in postponing appropriate treatment 
(Low et al., 2007). This may have a negative affect to the treatment outcome, and may 
prolong treatment durations and complex pain amongst the patients.  
 Currently, there is a lack of pediatric-focused diagnostic criteria, validated 
diagnostic tests that are highly sensitive and specific, age-based medication 
recommendations, and definitive and validated treatments in pediatric populations 
(Katholi et al., 2014). There have been several studies discussing the efficacy of an 
intensive, interdisciplinary rehabilitation approach in treating pediatric CRPS (Logan et 
al., 2012; Rodriguez-Lopez et al., 2015; Katholi et al., 2014; Wilder, 2006). One study 
discussed that physical therapy, in combination with appropriate invasive procedures and 
medications may be the most effective therapy in the treatment of CRPS (Wilder, 2006). 
Katholi et al. (2014) further concluded that children respond better to noninvasive 
approaches than adults in managing pain, and that family-centered therapies tailored 
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around the individual personality of the patient was the optimal model for treating 
pediatric CRPS. Another study utilized physiotherapy, psychological therapy, and 
pharmacological agents for the management of CRPS and performed invasive techniques 
like neuraxial bupivacaine infusion and spinal cord stimulation when noninvasive options 
did not alleviate the symptoms (Rodriguez-Lopez et al., 2015). Rodriguez-Lopez et al. 
(2015) also stated that early diagnosis is indicative of a better prognosis of the disorder, 
which is consistent with other studies’ findings (Low et al., 2007; Lee et al., 2002; 
Finniss et al., 2006; Berde and Lebel, 2005; Murray et al., 2000). In order to quickly and 
accurately diagnose pediatric CRPS and correspondingly offer multidisciplinary 
treatment, it is critical to validate diagnostically specific pediatric CRPS criteria.  
 
Current Treatments for CRPS 
 Due to the lack of information regarding the etiology and pathophysiology of 
CRPS, a standardized treatment plan or a consistent objective diagnostic test is not yet 
available. However, a multimodal program that integrates various therapies such as 
intensive physical therapy, occupational therapy, and cognitive behavioral therapy have 
consistently demonstrated improvement in decreasing pain levels and increasing function 
in adults and children afflicted with CRPS (Logan et al., 2012; Parkitny et al., 2015; Sahil 
et al., 2013). Yet the scarcity of evidence-based treatment regimens highlights how there 
are limited pharmacological agents and methods available for treating CRPS 
(Forouzanfar et al., 2002). Some of the agents used for pharmacological therapy of CRPS 
are: corticosteroids, calcitonin, nonsteroidal anti-inflmmatory drugs (NSAIDs), gamma-
	7 
aminobutyric acid (GABA) agonists, beta-blockers, and oral-sympatholytic agents (Tran 
et al., 2010). Additionally, there are several interventional procedures such as selective 
sympathetic ganglion nerve blocks, ketamine infusion, spinal cord and peripheral nerve 
stimulation, and surgical sympathetctomy, though it is not commonly used since such 
procedures are still controversial with unstable outcomes (Hsu, 2009).  
 
Interdisciplinary Approach to CRPS 
 Recently, a more comprehensive approach to CRPS has gained attention in 
decreasing pain and increasing function of CRPS patients. Interdisciplinary programs that 
incorporate psychotherapy, pharmacotherapy, drug therapy, and interventional treatment 
have reported success in the practical management of CRPS (Singh et al., 2004). Physical 
therapy and occupational therapy have also shown efficacy in alleviating the symptoms 
of CRPS (Hugle et al., 2011; Van de Meent et al., 2011; Tran et al., 2010). Furthermore, 
noninvasive, multidisciplinary treatments for CRPS that are family-oriented have 
reported high recovery rates, especially in the pediatric population (Katholi et al., 2014). 
These studies reflect the complicated and multifactorial nature of CRPS and hint at how a 
holistic approach tailored to individual patients may be the future of treating CRPS. 
 
Diagnostic Criteria for CRPS 
 An incomplete understanding of the etiopathology of CRPS resulted in a lack of a 
common, validated diagnostic criteria for CRPS. Thus in 1994, the International 
Association for the Study of Pain (IASP) developed the first diagnostic criteria for CRPS 
	8 
in hopes to provide a standardized methodology for determining whether the unidentified 
pain represented CRPS or not (Table 1) (Sebastin, 2011; Merskey & Bogduk, 1994). This 
diagnostic measure did not imply any pathophysiology, but rather was descriptive and 
general, intended to enhance clinical communication and identifying research samples 
(Harden et al., 2007). Because the criteria were determined solely by consensus, its 
potential has been limited and has not been utilized frequently in literature. Moreover, 
although the sensitivity of the IASP diagnostic criteria was high (0.98), specificity was 
poor with 0.36, which led to an over-diagnosis of CRPS (Bruehl et al., 1999). This lack 
of specificity may be due to several factors, such as how the criteria may be met based 
only on self-reported symptoms, failure to include trophic and motor features, and how 
edema and disproportionate pain was sufficient for diagnosis (Harden et al., 1999). Over-
diagnosis of CRPS may potentially lead to inaccurate or unnecessary treatments, and 
there was a dire need for an improvement to the original IASP CRPS criteria. 
Table 1: 1994 IASP Diagnostic Criteria for CRPS. Criteria 2, 3, and 4 must be 
satisfied for diagnosis. If seen without “major nerve damage” diagnose as CRPS I; if seen 
in the presence of “major nerve damage” diagnose as CRPS II. 
 
1. The Presence of an initiating noxious event, or a cause of immobilization. 
2. Continuing pain, allodynia, or hyperalgesia with in which the pain is 
disproportionate to any inciting event. 
3. Evidence at some time of edema, changes in skin blood flow, or abnormal 
sudomotor activity in the region of the pain. 
4. This diagnosis is excluded by the existence of conditions that would otherwise 
account for the degree of pain and dysfunction. 
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	 In 2003, an international consensus workshop was held in Budapest to discuss the 
issues pertaining to the limitation of CRPS diagnosis and to ultimately recommend 
modifications to the IASP criteria (Sebastin, 2011). In comparison to the IASP CRPS 
criteria, this modified diagnostic criteria, also known as the Budapest Criteria, was based 
mainly on published, empirically derived criteria (Harden et al., 2010). There are four 
main criteria: degree of pain, symptoms, signs, and diagnosis (Table 2) (Harden et al., 
2007; Harden et al., 2010). If the patient presents or communicates any of the 
subcategories within each criteria—for example, hyperalgesia under sensory or dystonia 
under motor—it counts as satisfying that category. The first question regards to whether 
the patient is experiencing pain that is disproportionate to the initial noxious event, and is 
expected that those who actually have CRPS would generally satisfy this criteria. The last 
question regards to whether a different diagnosis better explains the patient’s signs and 
symptoms, further minimizing misdiagnosis of CRPS. In order to make a clinical 
diagnosis, a patient must have at least two or more signs and three or more symptoms; 
this led to a sensitivity of 0.85 and a specificity of 0.69 (Harden et al., 2007). This result 
demonstrated an acceptable decision rule that correctly identified many patients clinically 
while significantly decreasing false-positive diagnosis that was evident with the previous 
IASP criteria. For research purposes, the decision rule was to satisfy at least two or more 
signs and all four symptoms categories, which resulted in a sensitivity of 0.70 and a 
specificity of 0.94 (Harden et al., 2007). This difference in the decision rule was due to 
the fact that it is critical to minimize false positives in the selection of research samples. 
This revision of the IASP diagnostic criteria established by the Budapest group 
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formulated two similar yet distinct sets of criteria that are optimized for specific 
purposes. 
Table 2: CRPS Budapest Diagnostic Criteria. For a clinical diagnosis, patients must 
present 2 or more signs and 3 or more symptoms. The decision rule for research purposes 
is to present at least 2 CRPS characteristics of the sign categories and in all 4 symptoms 
categories. 
 
  Yes = 1, No = 0 
1. Pain Continuous which is 
disproportionate to inciting 
event 
 
2. Symptoms   
• Sensory Hyperalgesia &/or 
allodynia, &/or deep 
somatic pressure pain, &/or 
joint movement pain 
 
• Vasomotor Temperature &/or skin 
color asymmetry 
 
• Sudomotor Sweating, dryness, &/or 
edema asymmetry 
 
• Motor Decrease ROM, weakness, 
tremor, dystonia, &/or 
changes in hair, nail or skin 
 
3. Signs on 
examination 
  
• Sensory Hyperalgesia &/or 
allodynia, &/or deep 
somatic pressure pain, &/or 
joint movement pain 
 
• Vasomotor Temperature &/or skin 
color asymmetry 
 
• Sudomotor Sweating, dryness, &/or 
edema 
 
• Motor Decrease ROM, weakness, 
tremor, dystonia, &/or 
changes in hair, nail or skin 
 
 TOTAL Score:  
4. Diagnosis Is there another diagnosis 
that better explains patient’s 
symptoms and signs? 
 
Additional Comments   
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Validation of the Budapest Criteria 
 In order to directly compare the IASP criteria and the Budapest Criteria and 
analyze their respective diagnostic efficiency, a validation study was imperative. In 2010, 
a validation study of the Budapest Criteria against the IASP criteria was conducted that 
involved 113 CRPS patients and 47 non-CRPS neuropathic pain patients at multiple data 
collection sites internationally (Harden et al., 2010). Countries where the study sites were 
located were Israel (31%), Germany (29.2%), Netherlands (25.6%), and the United States 
(14.1%) (Harden et al., 2010). Some of the diagnoses among the non-CRPS patients, 
supported by clear neuropathic etiology and appropriate testing, include isolated 
peripheral neuropathy, radiculopathy, carpal tunnel syndrome, and diabetic peripheral 
neuropathy (Harden et al., 2010).  
 A CRPS database checklist was employed across the sites in order to standardize 
the assessment of signs and symptoms. This checklist was a comprehensive list of the 
signs and symptoms utilized to diagnose CRPS, and a informative video was provided to 
the respective physicians on how to perform the data collection procedures so that there 
will be maximal uniformity across study sites (Harden et al., 2010).  
 The results showed that the Budapest clinical criteria demonstrated excellent 
sensitivity (0.99) that was comparable to that of the IASP criteria (1.00), and a higher 
specificity (0.68) contrast to the latter criteria (0.41) (Harden et al., 2010). The Budapest 
research criteria had the highest specificity (0.79) but the lowest sensitivity (0.78), which 
was expected as its purpose is to minimize false positives at the expense of sensitivity 
(Harden et al., 2010). It also showed through examining the positive and negative 
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predictive power that the Budapest clinical criteria demonstrated a better overall 
diagnostic accuracy compared to the IASP criteria, even under conditions where CRPS 
diagnoses was common: with 70% prevalence of CRPS among the patient population, the 
Budapest clinical criteria had 0.88 positive predictive power and 0.97 negative predictive 
power compared to IASP’s 0.80 and 1.00, respectively (Harden et al., 2010).   
 The study examined the contributions of each to the overall diagnostic accuracy 
of the Budapest Criteria, and found that although each individual component (sensory, 
vasomotor, sudomotor, and motor) had a relatively high sensitivity, specificity was low 
(Table 3) (Harden et al., 2010). Moreover, when the four components are used in 
combination, the sensitivity was the highest with 0.95, and the specificity was highest as 
well with 0.81 (Table 3). Thus it can be deduced that all the four diagnostic components 
must be included in diagnosing CRPS using the Budapest Criteria for optimal accuracy. 
In conclusion, this study validated the Budapest diagnostic criteria and highlighted its 
credibility over the IASP criteria, suggesting the former to be the standardized measure 
for clinical CRPS diagnosis (Harden et al., 2010).  
Table 3: Comparison of the Diagnostic Efficiency of Individual Budapest Criteria 
Diagnostic Components. The 4 individual components demonstrate relatively high 
sensitivity, but not as specific. Combination of all the components demonstrates the 
highest sensitivity and specificity. Retrieved from: Harden et al., 2010. 
 
Criterion Sensitivity Specificity 
All signs/symptoms factor 
scores 
0.95 0.81 
Sensory factor only 0.83 0.57 
Vasomotor factor only 0.94 0.68 
Sudomotor/edema factor 
only 
0.85 0.71 
Motor/trophic factor only 0.86 0.67 
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Objectives  
 Despite recent scientific progress and increased research in CRPS, there have 
been minimal advancements in pediatric CRPS. In order to develop pediatric-focused 
treatment protocols and appropriate medication recommendations, it is imperative to 
determine accurate diagnostic CRPS criteria for pediatric populations that have both high 
sensitivity and specificity. We utilized the Budapest Criteria, a validated diagnostic test 
that has demonstrated high sensitivity and specificity in an adult sample, and seek to 
analyze its diagnostic accuracy amongst the pediatric patient population.  
The specific aims of the study are: 
1. To evaluate the sensitivity and specificity of the Budapest Criteria in a pediatric 
sample, and compare with the adult criteria as well measure the likelihood ratios 
for the Budapest Criteria. 
2. To assess whether a cohort of pediatric CRPS patients who satisfied (Clinician + 
Budapest CRPS cohort) and did not satisfy the Budapest Criteria (Clinician 
Diagnosed CRPS cohort) both report a decrease in Budapest signs and symptoms 
score from the course of admission to PPRC until their discharge using a repeated 
measures ANOVA.  
We hypothesize that these studies will show: 
1. A high sensitivity and specificity of the Budapest Criteria when administered to 
pediatric patients, comparable to the adult findings. 
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2. A significant decrease in Budapest signs and symptoms, scores over time when 
comparing the scores at admission to the PPRC to those at discharge in both 
Clinician Diagnosed and Clinician + Budapest CRPS patients.	
	15 
METHODS 
 
 
Pediatric Pain Rehabilitation Center 
 The Mayo Family Pediatric Pain Rehabilitation Center at Boston Children’s 
Hospital at Waltham, commonly known as the PPRC, is a facility that provides an 
intensive day hospital interdisciplinary treatment approach to children with chronic pain. 
It is a day treatment rehabilitative program that accepts youth between ages 7 and 18, 
who suffer from chronic pain even after outpatient treatment (Simons et al., 2013; Logan 
et al., 2012). Some of the conditions the program admits are: CRPS, neuropathic pain, 
and musculoskeletal pain. The program is dedicated in tailoring their care to each 
individual, combining occupational therapy, physical therapy, psychological therapy, 
medical and nursing management, and therapeutic recreation in their treatment protocol 
(Boston Children’s Hospital). The daily regimen consists of intensive physical, 
occupational, and psychological therapies eight hours a day, five days a week, for 
approximately three to four weeks (Simon et al., 2013). These are aimed to minimize 
pain and restore normal levels of functioning, and are coupled with a family-centered 
therapy that allows family members to provide care outside of the hospital setting. The 
psychological therapy is based on a cognitive-behavioral model, and patients engage in 
both individual and group-based psychological therapy to encourage them to develop 
healthy attitude and habits in managing pain.  
 Every patient who is admitted to the PPRC is administered the Budapest Criteria 
for data collection. Our primary aim is to analyze this data and compare it against the 
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actual diagnosis to determine the efficacy of the Budapest Criteria in pediatric patients, 
mainly by measuring its sensitivity and specificity in the given pediatric population. We 
hypothesize that the Budapest Criteria will demonstrate comparative specificity and 
sensitivity in the pediatric patients as those of the adults, corroborating its utilization in 
the pediatric population. Furthermore, our secondary aim is to determine whether the 
multidisciplinary approach employed in the PRRC actually alleviates the signs and 
symptoms of CRPS over time. We hypothesize that there will be a significant decrease in 
in the Budapest signs, symptoms, and total score reported by the patients when 
comparing their data at admission against those at discharge.  
 
Data Collection 
 The Budapest Criteria was administered to a total of 221 patients at admission. A 
single physician conducted the Budapest Criteria to each pediatric patient. The test was 
given at admission prior to any treatment and at discharge after successful completion of 
the program.  
 
Patient Demographics 
 Of the 221 subjects, 182 of them were female, and 39 were male (Table 4). The 
subjects were predominantly Caucasian (87.3%) followed by  Hispanics (3.2%)  and 
Africans (3.2%), Asian subjects (1.4%), and 5 reporting as ‘other’ (2.3%) (Table 5). The 
mean age was 14.29 years old with a standard deviation of 2.77 years, and the mean 
duration of pain among them was 21.24 months (Table 6).  
	17 
 The sample included 106 patients diagnosed with CRPS prior to admission and 
112 patients with other chronic pain diagnoses including 75 patients with musculoskeletal 
pain, 30 with headache or abdominal pain, and 7 with neuropathic non-CRPS pain. 
Furthermore, 94 of the 106 CRPS patients had Budapest scores from admission and 
discharge; thus their data was utilized to investigate our secondary aim. Within the 94 
CRPS patients, 40 patients did not satisfy the Budapest clinical decision rule (Clinician 
Diagnosed CRPS group), and 54 patients did satisfy the Budapest clinical decision rule 
(Clinician + Budapest CRPS group). 
Table 4: Gender Distribution of Admitted Patients. The pediatric patient population 
admitted to the PPRC predominantly consisted of females. 
 
 Number of Patients Percent 
Male 39 17.6 
Female 182 82.4 
Total 221 100 
 
Table 5: Demographic Distribution Among the Patients. The racial demographics of 6 
patients were missing in the collected data.  
 
  
Number of Patients 
 
Percent 
 
Valid Percent 
Caucasian 193 87.3 89.8 
Asian 3 1.4 1.4 
Hispanic 7 3.2 3.3 
African American 7 3.2 3.3 
Other 5 2.3 2.3 
Total 215 97.3 100.0 
Missing 6 2.7  
Cumulative Total 221 100.0  
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Table 6: Age and Pain Duration Characteristics of the Pediatric Sample (n = 221) at 
Admission. 
 Minimum Maximum Mean Std. Deviation 
Age (years) 8.22 22.25 14.29 2.77 
Pain Duration 
(months) 
-37 186 21.24 27.53 
 
Statistical Analyses 
 Sensitivity and specificity of the Budapest were analyzed using SPSS Version 21. 
The clinical diagnostic decision rule for CRPS was utilized: for a clinical diagnosis, a 
patient must have at least 2 or more signs and 3 or more symptoms. Sensitivity is defined 
as a statistical measure that determines the proportion of positives cases that are 
accurately identified as positives: true positives / (true positive + false negative). Thus in 
this study, it reflects the accuracy of the Budapest Criteria in diagnosing CRPS in patients 
who actually have CRPS. Specificity is defined as a statistical measure that determines 
the proportion of negative cases that are accurately identified as negatives: true negatives 
/ (true negative + false positives). In this study, it reflects the accuracy of the Budapest 
Criteria in verifying those patients who do not have CRPS.   
 Positive and negative likelihood ratios were also calculated using SPSS in order to 
evaluate the value of performing the Budapest diagnostic criteria in pediatric CRPS 
patients. Likelihood ratios incorporate both sensitivity and specificity of the given test 
and provide a calculated estimate of how much the test result will affect the odds of 
having or not having a disease/disorder. Thus, a positive likelihood ratio (PLR) provides 
how much the odds of having the disease will increase when the test is positive. For 
example, if the PLR of a given diagnostic test for a disease is 10, and the pre-test odds—
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such as prevalence—of having the disease is 1%, the post-test odds = pre-test odds * 
PLR, so the probability of having the disease after the positive test result would be 
approximately 10%. PLR is calculated as: PLR = sensitivity / (1 - specificity). Similarly, 
a negative likelihood ratio (NLR) provides how much the odds of having the disease will 
decrease when the given test is negative. If the NLR of a given diagnostic test for a 
disease is 0.5, and the pre-test odds of having the disease is 10%, the post-test odds after 
multiplying those values would be 5. So with the negative test result, the probability of 
having the disease decreases to 5%. NLR is calculated as: (1 – sensitivity) / specificity.  
 Analyses were conducted to determine whether those diagnosed with CRPS 
experienced a decrease in the Budapest signs and symptoms score from admission to 
their discharge. The Budapest scores of 94 pediatric CRPS patients were used to run this 
analysis. There were four groups that were analyzed: signs scores of Clinician + Budapest 
CRPS patients, signs scores of Clinician Diagnosed CRPS patients, symptoms scores of 
Clinician + Budapest CRPS patients, and Clinician Diagnosed CRPS patients. Two 
repeated measures ANOVA were performed; one that analyzed the Budapest signs and 
symptoms scores of the Clinician Diagnosed CRPS cohort, and another that analyzed the 
Budapest signs and symptoms score of the Clinician + Budapest CRPS cohort. IBM’s 
SPSS predictive analytic software was utilized, and a repeated measure ANOVA was 
performed to analyze the data.  
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RESULTS 
 
 
 Among the 221 patients who were admitted to the PPRC, 106 patients were 
diagnosed with CRPS prior to admission. The patients’ Budapest Criteria data was 
analyzed to determine who met the clinical decision rule (report at least 2 or more signs 
and 3 or more symptoms) in order to calculate the sensitivity. Fifty-nine out of the 106 
patients met the clinical diagnostic criteria, whereas the other 47 patients did not (Table 
7). This resulted in a sensitivity of 0.56 (Table 8).  
Table 7: Contingency Table Examining the Association Between the Actual 
Diagnoses of the Patients and Their Reports on the Budapest Criteria.  
 
 Diagnosis 
Budapest Criteria CRPS Non-CRPS 
 
Positive 
 
59 
(True Positive) 
 
6 
(False Positive) 
 
Negative 
 
47 
(False Negative) 
 
106 
(True Negative) 
 
Table 8: Statistical Values for the Budapest Criteria in Pediatric Patients as 
Calculated from the SPSS Data 
 
Statistic Value 
Sensitivity 0.56 
Specificity 0.95 
Positive Likelihood Ratio 10.39 
Negative Likelihood Ratio 0.47 
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 The 112 patients that were admitted to the PPRC with non-CRPS pain disorders 
(musculoskeletal, headache or abdominal pain, and neuropathic non-CRPS pain) 
provided data to calculate specificity. Only 6 of the 112 patients met the clinical decision 
rule for CRPS, and the other 106 patients did not (Table 7). This resulted in a specificity 
of 0.95 (Table 8).  
 The values for sensitivity and specificity were used to calculate the likelihood 
ratios. The positive likelihood ratio was calculated to be 10.39, and the negative 
likelihood ratio was 0.47 (Table 8). The positive likelihood ratio of 10.39 corresponded to 
a value that is considered to significantly increasing the post-test probability of having 
the disorder when tested positive. The negative likelihood ratio corresponded to a value 
that fell in the range of only having a modest effect on decreasing the post-test 
probability of having the disorder when tested negative. 
 In order to determine whether the Clinician Diagnosed CRPS group (pediatric 
CRPS patients who satisfied the Budapest clinical criteria) and the Clinician + Budapest 
CRPS group (pediatric CRPS patients who did not satisfy the Budapest clinical criteria) 
experienced a significant decrease in pain, the CRPS patients’ Budapest scores at 
admission and discharge were analyzed. Out of the 106 CRPS patients, 94 patients’ 
Budapest scores were available. Within those 94 patients, there were 40 Clinician 
Diagnosed CRPS patients and 54 Clinician + Budapest CRPS patients.  
 We conducted a repeated measures ANOVA to explore changes in CRPS signs 
and symptoms from admission to discharge for both the Clinician + Budapest CRPS 
group (diagnosed by a physician prior to admission & verified by Budapest) and the 
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Clinician Diagnosed CRPS group (diagnosed by physician prior to admission but not 
meeting criteria on the Budapest). When looking at the signs and symptoms of patients 
who presented to the PPRC with a diagnosis of CRPS but which was not verified by the 
Budapest criteria at admission (see Figure 1), there was a main effect for time from 
admission to discharge, F(1, 78)=36.35, p < 0.001, indicating that both signs and 
symptoms significantly decreased over the course of treatment for this group as well. 
However, there was no significant interaction effect. When looking at the signs and 
symptoms of patients who presented to the PPRC with a diagnosis of CRPS and which 
was verified by the Budapest criteria at admission (see Figure 2), there was a main effect 
for time from admission to discharge, F(1, 106)=360.20, p < 0.001, indicating that both 
signs and symptoms significantly decreased over the course of treatment. There was no 
significant interaction effect, indicating that both signs and symptoms significantly 
improved over the course of treatment and but that the change in neither signs nor 
symptoms was more pronounced (i.e., a steeper slope) from admission to discharge.  At 
admission, the mean Budapest signs scores were 1.40 and 3.31 for the Clinician 
Diagnosed and Clinician + Budapest CRPS group, with a standard deviation of 0.928 and 
0.639, respectively (Table 9). At discharge, the mean Budapest signs scores were 0.70 
and 1.33 for the Clinician Diagnosed and Clinician + Budapest CRPS group, with a 
standard deviation of 0.608 and 0.739, respectively (Table 10). The mean symptoms 
scores at admission were 1.45 for the Clinician Diagnosed CRPS group and 3.54 for the 
Clinician + Budapest CRPS group, with a standard deviation of 0.904 and 0.503, 
respectively (Table 9). The mean symptoms scores at discharge were 0.67 for the 
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Clinician Diagnosed CRPS group and 1.46 for the Clinician + Budapest CRPS group, 
with a standard deviation of 0.730 and 0.926, respectively (Table 10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Repeated measures ANOVA analyses for Budapest signs and symptoms 
score of Clinician Diagnosed pediatric CRPS cohort. 
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Figure	2:	Repeated measures ANOVA analyses for Budapest signs and symptoms 
score of Clinician + Budapest pediatric CRPS cohort. 
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Table 9: Descriptive Statistics of Budapest Criteria at Admission (Clinician 
Diagnosed n = 40, Clinician + Budapest n = 54). 
 
Table 10: Descriptive Statistics of Budapest Criteria at Discharge (Clinician 
Diagnosed n = 40, Clinician + Budapest n = 54). 
  
 
 
 
 
Mean 
 
 
 
 
Std. Deviation 
 
 
 
 
Std. 
Error 
 
95% CI for Mean 
 
Lower 
Bound 
 
Upper 
Bound 
 
Signs of Clinician 
Diagnosed CRPS 
Group  
 
1.40 
 
 
0.928 
 
0.145 
 
1.112 
 
1.688 
Signs of Clinician + 
Budapest CRPS 
Group 
 
3.31 
 
 
0.639 
 
0.078 
 
3.160 
 
3.470 
Symptoms of 
Clinician Diagnosed 
CRPS Group 
 
1.45 
 
0.904 
 
0.145 
 
1.162 
 
1.738 
 
Symptoms of 
Clinician + Budapest 
CRPS Group 
 
3.54 
 
0.503 
 
0.078 
 
3.382 
 
3.692 
  
 
 
 
 
Mean 
 
 
 
 
Std. 
Deviation 
 
 
 
 
Std. 
Error 
 
95% CI for Mean 
 
Lower 
Bound 
 
Upper 
Bound 
 
Signs of Clinician 
Diagnosed CRPS 
Group  
 
0.70 
 
 
0.608 
 
0.106 
 
0.489 
 
0.911 
Signs of Clinician + 
Budapest CRPS 
Group 
 
1.33 
 
 
0.739 
 
0.126 
 
1.083 
 
1.584 
Symptoms of Clinician 
Diagnosed CRPS 
Group 
 
0.67 
 
0.730 
 
0.106 
 
0.464 
 
0.886 
 
Symptoms of Clinician 
+ Budapest CRPS 
Group 
 
1.46 
 
0.926 
 
0.126 
 
1.212 
 
1.714 
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Table 11: Comparison of the Diagnostic Efficiency of IASP CRPS Criteria Versus 
Proposed Modified (Budapest) Criteria for Discriminating Between CRPS-I and 
Non-CRPS Neuropathic Pain. Retrieved from: Harden et al., 2010.   
CRPS neuropathic pain. Retrieved from: Harden et al., 2010.   
Note: positive predictive power (PPP) and negative predictive power (NPP) are 
dependent on the assumed prevalence of CRPS in the population being considered. For 
illustrative purposes, two scenarios are presented in which either 70% or 50% of patients 
referred to rule CRPS in or out actually have the disorder. IASP = diagnosis based on 
presence of CRPS signs or symptoms using the International Association for the Study of 
Pain criteria. 
 
Table 12: General Interpretation Guideline for Likelihood Ratios (LR). Retrieved 
from: Cleland, 2005.  
 
 
 
 
Diagnostic 
criteria 
 
 
 
 
Sensitivity 
 
 
 
 
Specificity 
Assume 70% 
CRPS 
prevalence 
 
Assume 50% 
CRPS 
prevalence 
 
PPP NPP PPP NPP 
IASP 1.00 0.41 0.80 1.00 0.63 1.00 
Budapest 
clinical 
0.99 0.68 0.88 0.97 0.76 0.99 
Budapest 
research 
0.78 0.79 0.90 0.60 0.79 0.78 
 
Positive LR 
 
Negative LR 
 
Interpretation 
 
> 10 
 
 
< 0.1 
Generate large and often 
conclusive shifts in 
probability 
 
5 – 10 
 
0.1 – 0.2 
 
Generate moderate shifts 
in probability 
 
2 – 5 
 
0.2 – 0.5 
 
Generate small but 
sometimes important 
shifts in probability 
 
1 – 2 
 
0.5 – 1 
 
Alter probability to a 
small and rarely important 
degree 
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DISCUSSION 
 
 
 This study presents an investigation in the use of the Budapest Criteria in the 
pediatric population, along with an evaluation of PPRC’s multimodal treatment program 
in mitigating the signs and symptom of CRPS. The Budapest Criteria was evaluated by 
analyzing its sensitivity, specificity, and the likelihood ratios in the pediatric sample of 
this study. The efficacy of the PPRC’s multidisciplinary treatment approach in managing 
pediatric CRPS was measured according to the changes, if any, in the Budapest scores of 
pediatric CRPS patients at admission compared to those at discharge.  
 The primary hypothesis, that the Budapest Criteria will demonstrate both high 
sensitivity and specificity, has not been supported from this study. Compared to the 
sensitivity of the Budapest Criteria in the adult population observed in the validation 
study (0.99), the sensitivity of it in the pediatric sample was lower with 0.56 (Table 8; 
Table 11). This indicated that the proportion of pediatric CRPS patients that actually 
tested positive (satisfied the clinical decision rule) was 0.56 in the study, suggesting that a 
little less than half of the pediatric CRPS patients actually did not meet the Budapest 
Criteria. However, the specificity in the pediatric sample, which was 0.95, was 
considerably higher compared to that of the adult population, which was 0.68 (Table 8; 
Table 11). This result indicated that the proportion of non-CRPS patients that did not 
meet the Budapest Criteria decision rule was 0.95, highlighting that the vast majority of 
those without CRPS were correctly tested as so. Hence the hypothesis was partially 
supported in that regards. Such differences between the adult and pediatric populations 
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may be attributable to the fundamental differences between adult and pediatric CRPS. An 
example of one such difference is how CRPS mainly affects the upper extremities in 
adults whereas it involves mainly the lower extremities in children (Low et al., 2007; 
Wolter et al., 2016).  
 The secondary hypothesis that the Budapest signs and symptoms score will 
decrease from admission to discharge from the PPRC has been supported. Both the 
Clinician Diagnosed CRPS group and the Clinician + Budapest CRPS group displayed a 
significant decrease in the Budapest signs and symptoms score from admission to 
discharge, according to the repeated measures ANOVA conducted (Figure 1; Figure 2). 
The mean signs and symptoms scores for the Clinician Diagnosed CRPS group at 
admission were 1.40 and 1.45, respectively, but decreased to 0.70 and 0.67 when 
measured again at discharge (Table 9; Table 10). The mean signs and symptoms scores 
for the Clinician + Budapest CRPS group were 3.31 and 3.54, and those at discharge 
were 1.33 and 1.46, respectively (Table 9; Table 10). It is evident that although the signs 
and symptoms scores of the Clinician + Budapest CRPS group were higher at admission, 
the scores decreased at a greater rate than that of the Clinician Diagnosed CRPS group 
(Figure 1; Figure 2). These results further supported the hypothesis that the pediatric 
CRPS patients will report a significant decrease in their respective Budapest scores from 
admission to discharge. 
 
Sensitivity of the Budapest Criteria in Pediatric Sample 
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 The sensitivity, which directly measure the proportion of those with CRPS is 
accurately diagnosed as having CRPS, being relatively low with a value of 0.56 connoted 
that a considerable amount of pediatric CRPS patients did not satisfy the clinical 
diagnostic criteria of having at least 2 or more signs and 3 or more symptoms on the 
Budapest Criteria. This may be due to the Budapest Criteria itself; the Budapest Criteria 
was created mainly using data from adult CRPS studies, and was validated using an adult 
population (Harden et al., 2007; Harden et al., 2010). Therefore, the subcategories that 
have been incorporated in the signs and symptoms, along with the diagnostic decision 
rules, are solely based on the CRPS presentations and prevalence in the adult population.   
 Most of the data regarding CRPS are derived from adult studies (Goldschneider, 
2012). First, the role of neurogenic inflammation has been mainly investigated in adults. 
Protein extravasation, elevations in proinflammatory cytokines, and related inflammatory 
mediators have been observed in adult CRPS (Weber et al., 2001; Huygen et al., 2002; 
Munnikes et al., 2005; Schinkel et al., 2006). Furthermore, there have been a few studies 
examining whether there are alterations in peripheral innervation in adults with CRPS, 
but no data are reported in children (Albrecht et al., 2006; Oaklander et al., 2006). Thus 
the question remains unanswered as to whether children demonstrate similar changes in 
peripheral innervation and if so, how such changes contribute to the severity and 
presentation of the symptoms. The role of autonomic nervous system dysfunction has 
also been investigated in adults. For example, adult CRPS patients have reported with 
both cold and warm variants, while pediatric CRPS patients predominantly reports a 
cyanotic, cool extremity (Veldman et al., 1993; Tan et al., 2008). Hence these differences 
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in clinical presentations and studies, or lack thereof, may underlie the low sensitivity that 
resulted from this study, as the Budapest Criteria was created mostly with data on adult 
findings. The pathophysiology of CRPS in adult and children may not completely 
overlap, thus pediatric CRPS patients may not experience the exact signs and symptoms 
that adults do. This would result in not satisfying some of the criteria in the Budapest 
Criteria, which may partially explain why the sensitivity was low in this case.  
 Furthermore, this is consistent with the statement that pediatric CRPS is not well 
recognized by clinicians, resulting in diagnostic delays (Low et al., 2007). Perhaps the 
low sensitivity of the Budapest Criteria is contributing to the diagnostic delays, as it may 
improperly diagnose CRPS patients as not having CRPS. In the clinical setting, this 
misdiagnosis could lead to inaccurate treatment protocols, exacerbation of symptoms, 
unnecessary referrals, and delay of administering proper treatment regimen. Moreover, 
this could partially explain why pediatric CRPS has been underreported; if true pediatric 
CRPS patients are often misdiagnosed as having other pain disorders or neuropathic pain, 
the sheer number of true CRPS patients that qualifies for research purposes will be lower.  
 
Specificity of the Budapest Criteria in Pediatric Sample 
 The specificity was extremely high with a value of 0.95, which is higher than any 
of the diagnostic criteria investigated in the validation study (Table 8; Table 11). In fact, 
it was even higher than that of the Budapest research diagnostic decision rule (0.79). This 
is significant as the Budapest research decision rule (satisfy all 4 symptom categories and 
have at least 2 or more sign categories) was established to minimize false negatives at the 
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extent of sensitivity for research purposes. This indicates that the Budapest Criteria was 
extremely successful in accurately diagnosing pediatric patients who are not afflicted 
with CRPS as not having CRPS; out of 112 non-CRPS patients, only 6 patients resulted 
in satisfying the Budapest clinical decision rules whereas the other 106 patients were 
distinguished as not having CRPS (Table 8). This indicates the potential usefulness of the 
Budapest Criteria when utilized in the pediatric population. It would be preferential to 
utilize the Budapest Criteria in a setting where the chief purpose is to minimize false 
negatives, such as when recruiting for stringent research samples, as opposed to 
identifying as many CRPS patients as possible in a clinical setting (Harden et al., 2007).  
 This high specificity, coupled with the low sensitivity, indicates that a majority of 
pediatric non-CRPS patients, along with a considerable fraction of CRPS patients, did not 
satisfy the Budapest clinical diagnostic criteria. When looking simply at the specificity, it 
appears that the Budapest Criteria is effective in screening out those who do not have 
CRPS; but when observing the considerably low sensitivity (hence even true CRPS 
patients do not meet the criteria), it may be implied that in general, the pediatric CRPS 
and non-CRPS population do not satisfy the Budapest clinical criteria.  
 Such observation points to whether the clinical presentations of CRPS in the 
pediatric populations are not entirely similar to those of the adults. It could be that the 
signs and symptoms are more pronounced in adults compared to children. This could 
contribute as to why 47 out of 106 pediatric CRPS patients did not meet the Budapest 
clinical diagnostic decision rule. This underlies the fact that the etiology and 
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pathophysiologic mechanisms of CRPS is still currently unknown, especially so in 
pediatric terms.  
 The PPRC is a tertiary referral center, admitting children and adolescents that 
experience exacerbating chronic pain despite outpatient treatment at other facilities. Since 
the PPRC mostly admits the extreme cases of chronic pain, the signs and symptoms of 
non-CRPS chronic pain has been well examined and diagnosed at other facilities prior to 
admission. Thus there was a clear and established neuropathic etiology to the conditions 
non-CRPS patients had, whether it was headache, abdominal pain, musculoskeletal pain, 
or non-CRPS neuropathic pain. This further explains how most of the pediatric non-
CRPS patients successfully did not meet the Budapest Criteria, as the patients presented 
with obvious, non-overlapping chronic pain conditions differing from CRPS.  
 
Likelihood Ratios 
 Likelihood ratios were calculated in order to determine the efficacy of the 
Budapest Criteria in its ability to change the probability that CRPS is present or not 
present in the respective patients. Positive and negative predictive values were not 
calculated because the sample sizes in the CRPS and non-CRPS groups did not reflect the 
actual prevalence of the disorder in reality.  
 The PLR, which reflected the change in probability that CRPS is present when the 
Budapest diagnostic clinical decision rule is met, was 10.39 (Table 8). This value may be 
interpreted as: the Budapest Criteria, when met, significantly increases the probability of 
the pediatric patient having CRPS (Table 12). In other words, the confidence in the 
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diagnosis of CRPS increased about 10-fold after the patient satisfied the Budapest 
Criteria. This result actually supports the Budapest Criteria in diagnosing CRPS, as the 
test conclusively shifts the probability of disease if tested positive. 
 The NLR, which reflected the change in probability that CRPS is present when 
the Budapest diagnostic clinical decision rule is not met, was 0.47 (Table 8). Thus it may 
be implied from the study that if a pediatric patient did not satisfy the Budapest Criteria, 
the probability that the patient actually has CRPS would decrease by approximately 47%. 
Generally speaking, if a diagnostic test has a NLR of 0.47, it is considered to have a 
moderate effect on decreasing the probability of having the disorder (Table 12).   
 It can be concluded from the PLR and the NLR that while the Budapest Criteria 
significantly increases the probability of a pediatric patient having CRPS when the 
clinical decision rule is met, the diagnostic test only modestly decreases the probability of 
having CRPS when the clinical decision rule is not met. This parallels the notion that the 
larger the PLR value the better the diagnostic test, and the smaller the NLR value the 
better the diagnostic test. However, the utility of the test decreases when either of the 
likelihood ratios approaches 1. It is important to note that likelihood ratios may influence 
clinical decision-making in three possible ways (Straus et al., 2005). First, the likelihood 
post-test probability is very high, indicating that the condition is present and further 
testing is unnecessary. This would be in the case when utilizing a diagnostic test with a 
very high PLR. Second, the likelihood of having the condition is so low that the clinician 
can rule out the diagnosis. Third, if the shift in probability of having the disease is 
inconclusive, it encourages clinicians to consider other alternate diagnostic tests. Hence 
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likelihood ratios are a powerful tool that integrates the results of a diagnostic test into 
clinical decision-making, in order to optimize the respective diagnoses (Hayden & 
Brown, 1999; Grimes & Schulz, 2005). The PLR and NLR values from this study 
indicate that while Budapest Criteria is excellent in substantiating confidence that CRPS 
is present when testing positive, the test should be used with caution when the patient 
does not meet the criteria and supplemental testing may be necessary.  	
The Efficacy of Intensive Rehabilitation Treatment on CRPS Outcomes: Repeated 
Measures ANOVA 
 Repeated measures ANOVA comparing the Budapest signs and symptoms scores 
at admission with those at discharge for the Clinician + Budapest and Clinician 
Diagnosed CRPS cohorts indicated a significant main effect for time, meaning that 
patients with CRPS had a significant resolution of signs and symptoms from admission to 
discharge (Figure 1; Figure 2). There were no significant interaction effects observed in 
both the Clinician Diagnosed and Clinician + Budapest CRPS cohorts. The mean 
Budapest signs and symptoms score at admission for the 40 Clinician + Budapest CRPS 
patients were 3.31 and 3.54, whereas those at discharge were 1.33 and 1.46, respectively 
(Table 9; Table 10). The Clinician Diagnosed CRPS cohorts also demonstrated a 
decrease in the mean Budapest signs and symptoms score, from 1.40 and 1.45 to 0.70 and 
0.67, respectively (Table 9; Table 10). This significant decrease in the Budapest score 
indicates that the PPRC’s holistic approach, which integrates occupational therapy, 
physical therapy, psychological therapy, recreational activities, among others, has been 
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successful in not only managing CRPS, but also in alleviating the signs and symptoms 
associated with it.  
 This finding is consistent with other findings that suggest that interdisciplinary, 
noninvasive treatment regimen is effective in reducing disability and improving 
psychological and physical performance (Logan et al., 2012; Low et al., 2007; Wilder, 
2006; Katholi et al., 2014). It is particularly encouraging since PPRC is a tertiary referral 
center, meaning that the facility receives patients that have already been unsuccessful 
with outpatient treatment. Therefore, this corroborates the utilization of multidisciplinary 
care in treating pediatric CRPS, even if the patient is resistant to traditional medications 
and pharmacological therapy.   
 
Overall Evaluation of the Budapest Criteria 
 The diagnosis of pediatric CRPS using the Budapest Criteria is recommended 
with reservation. After evaluating its sensitivity and specificity (relatively low and high 
compared to the adult findings, respectively), it may be deduced that the Budapest 
Criteria is effective in terms of minimizing false negatives, but not necessarily in 
maximizing clinical identification of CRPS patients. Thus the Budapest Criteria may be 
beneficial when used to identify stringent research samples but not necessarily in clinical 
decision-making.  
 The likelihood ratios also provided insight regarding the utility of the Budapest 
Criteria by exploring the diagnostic results and its potential effects on clinical judgment. 
The high PLR (10.39) and the moderate NLR (0.47) suggested that while a positive test 
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significantly increases the odds of the patient actually having CRPS, a negative test only 
moderately decreases the odds of the patient actually having CRPS (Table 8). Thus if a 
patient is tested negative on the Budapest Criteria but the clinician still harbors a 
considerable suspicion, additional testing may be required.  
 These results suggest that a modified pediatric CPRS criteria must be explored 
that will demonstrate a high sensitivity while maintaining the high specificity that was 
demonstrated in this study. Pediatric CRPS may have similar pathophysiologic 
mechanisms to adult CRPS, but clinical manifestations may differ. Some possible 
differences might include but are not limited to: pain threshold, degree of signs and 
symptoms, and the nature of signs and symptoms. The Budapest Criteria was established 
upon adult CRPS studies and findings; therefore, it is imperative to fully examine the 
signs and symptoms prevalent for pediatric CRPS and create the appropriate 
subcategories in the Budapest Criteria to optimize diagnostic accuracy.  	
Interdisciplinary Treatment of Pediatric CRPS 
 Through repeated measures ANOVA analyses of the Budapest scores of pediatric 
CRPS patients, it has been exemplified that the PPRC has been successful in decreasing 
the patients’ pain levels through their enrollment to the day treatment rehabilitative 
program. This outcome is consistent with other studies examining the efficacy of 
multidisciplinary pediatric pain rehabilitation centers (Odell & Logan, 2013; Wilder, 
2006; Stanos, 2012; Turk, 2002). However, compared to the abundance of studies 
regarding adult pain centers, there is a scarcity of research done on pediatric pain 
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rehabilitation centers (Odell & Logan, 2013). Furthermore, the larger issue is that there 
are only a handful of studies actually examining the mechanisms behind the 
multidisciplinary approach (Odell & Logan, 2013). There is a dire need to elucidate the 
processes and mechanisms that enable programs like PPRC to be successful in 
significantly reducing pain and improving function. Thus observing and analyzing the 
multidisciplinary pediatric pain programs’ treatment regimens will first provide insight 
into optimal treatment structure. Further analyzing the CRPS patients’ profile and clinical 
manifestations through retrospective chart review may possibly clarify the 
pathophysiology of CRPS. Through these studies, it may be possible in the near future to 
develop a standardized protocol that will effectively manage and treat the signs and 
symptoms of not only CRPS, but also for other chronic pain conditions as well. Inter-
program collaboration will indeed provide the data necessary to conduct further research 
into the field of pediatric chronic pain. 
 
Evaluation of Study Design 
 One of the strengths of this study was that a single physician administered the 
Budapest Criteria to the pediatric patients at the PPRC. This allowed for consistency in 
evaluating the patients’ signs and symptoms, with minimal discrepancy in the evaluation 
method. Another factor that contributed to the validity of the study was the large sample 
size. Having 218 pediatric pain patients to evaluate the sensitivity, specificity, and 
likelihood ratios of the Budapest Criteria substantiated the results of the study. The large 
sample size not only is more representative of the pediatric pain population, but also 
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minimizes the effects of outliers and maximizes the accuracy of the extrapolated data 
regarding the Budapest Criteria. Being able to utilize 94 patients’ Budapest scores at 
admission and discharge (in order to assess whether PPRC was successful in alleviating 
the signs and symptoms of CRPS) also benefited from the advantages of having a large 
sample size.  
 The limitations of this study consist of the lack of Budapest data at certain time 
points for several patients. Out of the 221 admitted pediatric patients, 3 of the patients’ 
data were not available. Furthermore, we were not able to use 12 of the 106 pediatric 
CRPS patients’ Budapest Criteria to examine the difference at admission vs. discharge, as 
the data was missing at either one point or at both points. The decrease in sample size due 
to such factors may have slightly decreased the representative value of the results in this 
study.  
 
Future Directions 
 In continuation of this study, we are determined to first relocate the Budapest 
Criteria reports of all 106 pediatric CRPS patients. This is made possible by consulting 
the electronic medical records with the physician that administered the Budapest Criteria 
to the patients and completing the Budapest Criteria for each patient accordingly. 
Because the physician administered these Budapest Criteria at various times—admission, 
discharge, first follow up (1 month), second follow up (6 months), and third follow up (1 
year)—we will be able to perform a repeated measures ANOVA on the pediatric CRPS 
patients at five time points. The increase in sample size and in the number of time points 
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will provide greater insight in regards to the efficacy of multidisciplinary treatment for 
pediatric CRPS.  
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